Table 3 Comparison of the clinical outcome of mNGS-positive and -negative group
mNGS positive (n = 24) | mNGS negative (n = 20) | P value | |
|---|---|---|---|
LOS (days) | 39 (20.75, 58.75) | 23.0 (21, 45) | 0.140 |
ICU admission | 21 (87.5%) | 15 (75%) | 0.436 |
In-hospital mortality | 7 (29.2%) | 4 (20.0%) | 0.484 |
Invasive intervention | |||
Numbers of PCD | 2 (1, 3) | 0 (0, 1) | 0.004 |
Requiring of PEN | 4 (16.7%) | 1 (5.0%) | 0.225 |
Requiring of ON | 8 (33.3%) | 1 (5.0%) | 0.020 |
Gastrointestinal fistulas | 4 (16.7%) | 1 (5.0%) | 0.225 |
Abdominal bleeding | 6 (25.0%) | 3 (15.0%) | 0.413 |
New-onset sepsis | 12 (50.0%) | 5 (25.0%) | 0.090 |
New-onset septic shock | 12 (50.0%) | 4 (20.0%) | 0.039 |
New-onset organ failure | 11 (45.8%) | 4 (20.0%) | 0.072 |